Cell proliferation measured by MIB1 and timing of surgery for breast cancer.

@article{Cooper1998CellPM,
  title={Cell proliferation measured by MIB1 and timing of surgery for breast cancer.},
  author={Lawton S. Cooper and Cheryl E. Gillett and P. Smith and Ian S. Fentiman and Diana M. Barnes},
  journal={British Journal of Cancer},
  year={1998},
  volume={77},
  pages={1502 - 1507}
}
We have investigated the use of the antibody MIB1 as a proliferative and prognostic marker in breast cancer and whether changes in proliferative activity could account for differences in prognosis of premenopausal women operated on during different phases of the menstrual cycle. MIB1 expression was strongly correlated with S-phase fraction and histological grade. There was no difference in MIB1 scores between different phases of the menstrual cycle. Both MIB1 score and timing of surgery… CONTINUE READING
13 Citations
34 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 34 references

Assessment of the new proliferative marker MIB

  • SE Pinder, P Wencyk, +6 authors IO Ellis
  • 1995
1 Excerpt

Assessment of the new proliferative marker MIB 1 in breast carcinoma using image analysis : associations with other prognostic factors and survival

  • PS Stonelake, J Powell, +4 authors JM Morrison
  • Br J Cancer
  • 1995
1 Excerpt

Influence of timing of surgery during menstrual cycle on survival of premenopausal women with operable breast cancer

  • JH vanDierendonk, R Keijezer, van de Velde CJH, CJ Comelisse
  • 1995

Surgical procedure can explain varying influence of menstrual cycle on prognosis of premenopausal breast cancer patients

  • RA Walker, RS Camplejohn
  • 1995

The timing of breast cancer surgery with respect to the menstrual cycle . More data which emphasise the need for a prospective study

  • R Peto, MC Pike, +7 authors PG Smith
  • Breast
  • 1995

Similar Papers

Loading similar papers…